Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol

Abstract Background ‘Clinically important deterioration’ (CID) is a composite endpoint measuring worsening of the key clinical features of chronic obstructive pulmonary disease (COPD), namely lung function, patient-reported outcomes, and exacerbations. ACLIFORM and AUGMENT were two 24-week, randomiz...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dave Singh, Anthony D. D’Urzo, Ferran Chuecos, Anna Muñoz, Esther Garcia Gil
Format: Artigo
Langue:Inglês
Publié: BMC 2017-05-01
Collection:Respiratory Research
Sujets:
COPD
LABA
LAMA
Bronchodilation
Chronic respiratory disease
Accès en ligne:http://link.springer.com/article/10.1186/s12931-017-0583-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires